LAXACIN is a Oral Tablet in the Human Otc Drug category. It is labeled and distributed by Direct Rx. The primary component is Docusate Sodium; Sennosides A And B.
| Product ID | 61919-497_838584ec-1cff-b130-e053-2a91aa0a70a1 | 
| NDC | 61919-497 | 
| Product Type | Human Otc Drug | 
| Proprietary Name | LAXACIN | 
| Generic Name | Laxacin | 
| Dosage Form | Tablet | 
| Route of Administration | ORAL | 
| Marketing Start Date | 2018-03-26 | 
| Marketing Category | OTC MONOGRAPH NOT FINAL / OTC MONOGRAPH NOT FINAL | 
| Application Number | part334 | 
| Labeler Name | DIRECT RX | 
| Substance Name | DOCUSATE SODIUM; SENNOSIDES A AND B | 
| Active Ingredient Strength | 50 mg/1; mg/1 | 
| NDC Exclude Flag | N | 
| Listing Certified Through | 2020-12-31 | 
| Marketing Start Date | 2018-03-26 | 
| NDC Exclude Flag | N | 
| Sample Package? | N | 
| Marketing Category | OTC monograph not final | 
| Application Number | part334 | 
| Product Type | HUMAN OTC DRUG | 
| Billing Unit | EA | 
| Marketing Start Date | 2019-08-28 | 
| Marketing Category | OTC monograph not final | 
| Application Number | part334 | 
| Product Type | HUMAN OTC DRUG | 
| Billing Unit | EA | 
| Marketing Start Date | 2018-03-26 | 
| Ingredient | Strength | 
|---|---|
| DOCUSATE SODIUM | 50 mg/1 | 
| SPL SET ID: | 68526336-76bb-7eac-e053-2a91aa0a751e | 
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | 
| NDC | Brand Name | Generic Name | 
|---|---|---|
| 45865-708 | Laxacin | Docusate sodium and sennosides | 
| 50488-0901 | Laxacin | Docusate sodium and sennosides | 
| 55700-930 | Laxacin | Docusate sodium and sennosides | 
| 61919-497 | LAXACIN | LAXACIN | 
| 68071-1549 | Laxacin | Docusate sodium and sennosides | 
| 68258-4985 | Laxacin | Docusate sodium and sennosides | 
Mark Image Registration | Serial  | Company  Trademark Application Date  | 
|---|---|
![]() LAXACIN  86119347  4555933 Live/Registered  | 
        Alexso, Inc.  2013-11-14  |